Advanced Search Results For "Menno V. Huisman"
Your filters
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF RegistryResearch in context
Publication Type: Academic Journal
Source(s): EClinicalMedicine, Vol 55, Iss , Pp 101757- (2023)
Abstract: Summary: Background: The ‘Atrial fibrillation Better Care’ (ABC) pathway has been proposed to streamline a more holistic or integrated care approach to atrial fibrillation (AF) management. We aimed to analyse the impact of adherence to the ABC pathway ...
Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices
Publication Type: Academic Journal
Source(s): Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Abstract: Left ventricular assist device (LVAD) implantation as destination therapy (DT) is a valuable treatment option in patients with end-stage heart failure ineligible for heart transplant. However, this therapy can be complicated by life-threatening pump th...
Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry
Publication Type: Academic Journal
Source(s): Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 15 (2022)
Abstract: Background Residual risk of ischemic stroke despite anticoagulation in patients with atrial fibrillation (AF) represents a significant clinical issue that remains unaddressed. We aimed to evaluate the incidence and risk factors for residual adverse eve...
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world
Publication Type: Academic Journal
Source(s): Journal of Arrhythmia, Vol 37, Iss 4, Pp 990-1006 (2021)
Abstract: Abstract Background Prescribing patterns for stroke prevention in atrial fibrillation (AF) patients evolved with approval of non‐Vitamin K antagonist oral anticoagulants (NOACs) over time. Objectives To assess changes in anticoagulant prescription patt...
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
Publication Type: Academic Journal
Source(s): Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Abstract: Background Effective stroke prevention with oral anticoagulants (OAC) is recommended for some patients with atrial fibrillation (AF). We aimed to describe OAC use by geographical region and type of site in patients with recent‐onset AF enrolled in a la...
First do no harm
Publication Type: Academic Journal
Source(s): Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
Publication Type: Academic Journal
Source(s): PLoS ONE, Vol 17, Iss 10 (2022)
Abstract: Objective To assess baseline characteristics and antithrombotic treatment (ATT) prescription patterns in patients enrolled in the third phase of the GLORIA-AF Registry Program, evaluate predictors of treatment prescription, and compare results with pha...
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
Publication Type: Academic Journal
Source(s): Hellenic Journal of Cardiology, Vol 62, Iss 2, Pp 152-157 (2021)
Abstract: Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific ...
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
Publication Type: Academic Journal
Source(s): Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 3, Pp 412-420 (2021)
Abstract: Abstract Background Whereas accumulating studies on patients with coronavirus disease 2019 (COVID‐19) report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infection...
Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF
Publication Type: Academic Journal
Source(s): ESC Heart Failure, Vol 7, Iss 5, Pp 2679-2689 (2020)
Abstract: Abstract Aims This study aimed to describe baseline characteristics of patients with atrial fibrillation (AF) at risk of stroke with and without history of heart failure (HF) and report 2‐year outcomes in the dabigatran‐treated subset of a prospective,...